Anzeige
Mehr »
Login
Mittwoch, 04.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Analysten eilen, um Kursziele zu verdreifachen nach ATHAs neuester Entdeckung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 23.11.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
23.11.Hungarian Academy of Sciences: World Science Forum 2024 Declaration Calls for Strengthening Trust in Science Globally476Discussions on future role of science continue in Indonesia in 2026BUDAPEST, Hungary, Nov. 23, 2024 (GLOBE NEWSWIRE) -- The 11th World Science Forum, held in Budapest, Hungary, on 20-23 November, ended...
► Artikel lesen
23.11.VivoPower International PLC Receives Notice from Nasdaq Regarding Compliance with Form 20-F Filing Requirements332Delay in filing form 20F has been due to the significant strategic changes pursuant to a previously announced strategic review Notification does not affect the Company's current listing status Company...
► Artikel lesen
23.11.BridgeBio Pharma, Inc.: Attruby (acoramidis), a Near Complete TTR Stabilizer (=90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients297- Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR. Attruby has been shown to preserve the native function of TTR as a transport protein of...
► Artikel lesen
23.11.Elevai Labs Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance345NEWPORT BEACH, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Elevai Labs Inc. (NASDAQ: ELAB) (Elevai" or the "Company") announced today it will implement a 1-for-200 reverse stock split ("Reverse Stock...
► Artikel lesen